Improved Outcomes With the Evolution of a Neoadjuvant Chemotherapy Approach to Right Heart Sarcoma Academic Article uri icon

Overview

MeSH Major

  • Antineoplastic Agents
  • Heart Neoplasms
  • Sarcoma

abstract

  • Neoadjuvant chemotherapy followed by radical surgery is a safe and effective strategy in patients with primary right-side heart sarcoma. This multimodality treatment enhances resectability (R0 resection) that translates into improved patient survival.

publication date

  • January 2017

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1016/j.athoracsur.2016.10.054

PubMed ID

  • 28189277

Additional Document Info